Education
About Us
Working with TipRanks
Follow Us
Solasia Pharma KK (JP:4597)
:4597
Total Valuation
Solasia Pharma KK has a market cap or net worth of ¥8.33B. The enterprise value is ¥6.70B.
Market Cap¥8.33B
Enterprise Value¥6.70B
Share Statistics
Solasia Pharma KK has 269,209,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding269,209,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Solasia Pharma KK’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -46.08%.
Return on Equity (ROE)-0.50
Return on Assets (ROA)-0.41
Return on Invested Capital (ROIC)-46.08%
Return on Capital Employed (ROCE)-0.47
Revenue Per Employee18.65M
Profits Per Employee-38.09M
Employee Count23
Asset Turnover0.20
Inventory Turnover2.30
Valuation Ratios
The current PE Ratio of Solasia Pharma KK is ―. Solasia Pharma KK’s PEG ratio is 0.13.
PE Ratio―
PS Ratio16.06
PB Ratio3.93
Price to Fair Value3.93
Price to FCF-8.13
Price to Operating Cash Flow-10.35
PEG Ratio0.13
Income Statement
In the last 12 months, Solasia Pharma KK had revenue of 429.00M and earned -876.00M in profits. Earnings per share was -3.69.
Revenue429.00M
Gross Profit171.00M
Operating Income-859.00M
Pretax Income-876.00M
Net Income-876.00M
EBITDA-822.00M
Earnings Per Share (EPS)-3.69
Cash Flow
In the last 12 months, operating cash flow was -847.00M and capital expenditures -211.00M, giving a free cash flow of -1.06B billion.
Operating Cash Flow-847.00M
Free Cash Flow-1.06B
Free Cash Flow per Share-3.93
Dividends & Yields
Solasia Pharma KK pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.88
52-Week Price Change-16.22%
50-Day Moving Average29.68
200-Day Moving Average33.90
Relative Strength Index (RSI)57.08
Average Volume (3m)41.98M
Important Dates
Solasia Pharma KK upcoming earnings date is May 20, 2026, TBA (Not Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Solasia Pharma KK as a current ratio of 6.06, with Debt / Equity ratio of 9.08%
Current Ratio6.06
Quick Ratio5.70
Debt to Market Cap0.01
Net Debt to EBITDA1.49
Interest Coverage Ratio-61.36
Taxes
In the past 12 months, Solasia Pharma KK has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Solasia Pharma KK EV to EBITDA ratio is -6.89, with an EV/FCF ratio of -6.68.
EV to Sales13.19
EV to EBITDA-6.89
EV to Free Cash Flow-6.68
EV to Operating Cash Flow-6.68
Balance Sheet
Solasia Pharma KK has ¥1.39B in cash and marketable securities with ¥159.00M in debt, giving a net cash position of ¥1.23B billion.
Cash & Marketable Securities¥1.39B
Total Debt¥159.00M
Net Cash¥1.23B
Net Cash Per Share¥4.56
Tangible Book Value Per Share¥7.38
Margins
Gross margin is 39.86%, with operating margin of -200.23%, and net profit margin of -204.20%.
Gross Margin39.86%
Operating Margin-200.23%
Pretax Margin-204.20%
Net Profit Margin-204.20%
EBITDA Margin-191.61%
EBIT Margin-200.23%
Analyst Forecast
The average price target for Solasia Pharma KK is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast243.16%
EPS Growth Forecast-23.00%